Νέα

Glasgow, Scotland, Wednesday, January 31 st , 2018. HCi Viocare (OTCQB:VICA) , is pleased to announce that its management, acknowledging the tremendous advantages of Blockchain technology, has decided to develop its own proprietary Blockchain based system for handling the sensitive client records in its Scottish Clinics subsidiary. Furthermore,... more
UPDATE Effective January 25 2018, Tharawat Holdings and HCi Viocare, have mutually decided that the formation of the JV that was agreed between them in July 2017, is no longer viewed as a strategic priority and have therfore terminated the Joint Venture Agreement between them. The management of HCi Viocare intents to re-evaluate this decision from... more
GLASGOW, SCOTLAND--(Marketwired - Oct 9, 2017) - HCi Viocare ("the Company" ( OTCQB : VICA )) is delighted to welcome Dr. John Doupis, MD, PhD to its team. Dr. Doupis joins the Scientific Advisory Board assuming the role of Director of Clinical Matters and Diabetes. Dr. Doupis is a former Clinical Research Fellow of the Joslin Diabetes Center,... more
Βρισκόμαστε στην ευχάριστη θέση να ανακοινώσουμε ότι βρισκόμαστε σε συζητήσεις με την εταιρία Tharawat του Βασιλείου της Σαουδικής Αραβίας, για την πιθανή συνεργασία μας με αντικείμενο της Κλινικές Προσθετικής, Ορθωτικής και Δαβητικού ποδιού.more

Σελίδες